drugset / Trial / NCT02946892

Effect of Carvedilol on Exercise Performance in Fontan Patients

NCT02946892

RandomizedCrossoverQuadruple-blindTreatment

Summary

This study evaluates the effect of carvedilol in patients who have undergone a Fontan heart operation. All participants will receive carvedilol and placebo for 12 weeks. Exercise tests will be performed at the end of each 12 week period.

Timeline

Start
2016-11
Primary completion
2019-12
Completion
2020-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Carvedilol Other / unclassified